Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-21
SponsorNew York Medical College
About this trial
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.
Eligibility criteria
Qualifiers
The subject's age of onset of pulmonary hypertension must be prior to age 18 years
The person providing consent must be able to read either Spanish or English.
The subject (and/or parent/legal guardian) must be able to provide informed consent
Disqualifiers
Diagnosed with pulmonary hypertension after age 18
Refusal to sign informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,500 Participants
are grouped into 1 trial groupSponsors and collaborators
New York Medical College
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Janssen Pharmaceuticals
Collaborator
Source ClinicalTrials.gov